Skip to main content
Premium Trial:

Request an Annual Quote

Waters Said Organic Q1 Revenues Grew 3 Percent; Income Up 14 Percent

NEW YORK, April 26 (GenomeWeb News) - Waters today said that first-quarter revenues increased 5 percent to $268.3 million from $255.1 million year over year.


Waters said that a foreign currency translation benefit accounted for approximately 2 percent of its first-quarter revenue growth, meaning that organic growth amounted to 3 percent.


Waters spent $16.7 million on research and development during the first quarter, a slight increase over the $16.1 million spent on R&D in the same quarter last year.


The company said net income for the three months ended March 31 increased 14 to $46.6 million, or $.39 per basic share, from $40.8 million, or $.34 per basic share, in the year-ago period.


Waters said that cash and cash equivalents on hand totaled $587 million as of April 2.


On March 29, Waters revised its estimate of 2005 sales growth to between 3 and 4 percent from the 13- to 14-percent range it identified in a January conference call with investors. The company also revised its projected first-quarter per-share earnings from $.44 to between $.34 and $.37. In a statement, the firm said that the lowered earnings were the result of "weaker than expected sales growth."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.